Search CORE

1 research outputs found

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Author: Albota A
Arslan M
Bach-Kliegel B
Bacun T
Balci MK
Balen MJ
Bartley P
Bauduceau B
Bebakar WM
Bebakar WW
Bednarczyk-Kaluzny M
Bhana S
Bhansali A
Biniszkiewicz T
Brändle M
Brändle M
Chandalia HB
Chen JF
Chow F
Christ E
Chuang LM
Cohen O
Colagiuri S
Colagiuri S
Comlekci A
Courreges JP
Dayan A
De Loredo L
Deerochanawong C
Derezinski T
Duevezin-Caubet P
Eriksson J
Filipczak R
Gaczarek-Belczyk E
Gaillard R
Galtier F
Gouet D
Gumprecht J
Ho YK
Honka M
Honkasalo M
Hristov V
Hristozov K
Hyun BS
Ilvesmaki V
Issa C
Kallioniemi V
Kamaruddin NA
Kamaruddin NA
Kamp M
Karnieli E
Karrasch J
Karrasch J
Karsidag K
Kittivat N
Kokic S
Korsoff P
Kuleta J
Kuo SW
Kuusisto A
Lakha D
Latiff G
Lauhawatana S
Le Devehat C
Le Thi TD
Lehmann R
Litwak L
Lopatynski J
Lorcy Y
Lowy A
Lowy A
Mader P
Maffei L
Majkowska L
Marre M
Marre M
Miarka J
Mikolajczyk-Swatko A
Mitha E
Mogos T
Moore R
Mumtaz M
Panelo A
Pavlova M
Pelikanova T
Perusicova J
Petkova M
Petrova-Gancheva A
Piippo T
Pontiroli A
Pop L
Popa B
Protich M
Que T
Racho V
Rahtu M
Raz I
Rodriguez M
Rusavy Z
Russell A
Santeusanio F
Sargin H
Serban V
Seshadri KG
Shah S
Shaw J
Shaw J
Skokowska E
Smahelova A
Squatrito S
Strand J
Strand J
Sy RA
Taek WJ
Taskinen M
Tu ST
Vines G
Waitman J
Wojciechowska M
Wolnik B
Zackova V
Zdravkovic M
Publication venue: Blackwell Publishing Ltd
Publication date: 01/01/2009
Field of study

Bern Open Repository and Information System (BORIS)

core

core